CUBEX® LLC MedBank™ Solutions Releases Significant Software Enhancement Providing Greater Security for Controlled Substance Access and Administration

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

PHOENIX, Sept. 19, 2019 /PRNewswire/ — CUBEX LLC’s MedBank™ Solutions, a leading provider of first dose and emergency medication technology, today announced a significant software enhancement to its cloud-based workflow solution, introducing new functionality that enables a two-way, verification alert process for the validation of controlled substances dispensed from MedBank automated dispensing cabinets. 

Serving a crucial role in the care continuum, closed-door pharmacies are facing increased pressure to ensure medication availability and safety to long-term care customers. The new functionality, RxVerify, drives time savings for closed-door pharmacies and long-term care facilities by increasing workflow efficiency, improving medication availability and ensuring regulatory safety and compliance. 

The RxVerify feature tightens security and streamlines the approval process by giving the pharmacy enhanced control over controlled substance access and administration. With the simple touch of a button at the cabinet in the LTC facility, an approval request is sent via text or email to the pharmacy. Upon pharmacy approval, a unique validation code automatically populates the patient’s profile at the cabinet.  Whereby, the nurse is immediately notified of the approval, via text or email, without ever having to call the pharmacy.  An alert is also posted on the cabinet so that any nurse attending to the patient can access the medication.

“Our goal for RxVerify is simple – to provide a timely, secure, and efficient medication verification process that allows pharmacists and clinicians to remain focused on delivering quality patient care,” said Michael Boivin, President of MedBank Solutions. “This new enhancement ensures patient safety and regulatory compliance while reducing the administrative burden for pharmacies and care facilities.”

RxVerify is available now. Contact sales@cubex.com for more information.

About CUBEX® LLC MedBank Medical Solutions

MedBank Medical Solutions is a leading provider of innovative health care automation and cloud-based business intelligence solutions that enable institutional pharmacies and alternative healthcare providers to improve medication care, cost and compliance. Through their closed-loop ecosystem, which includes seamless integration with Electronic Medical Records and Pharmacy Information Management Systems, MedBank empowers healthcare facilities to improve medication availability of emergent medications, thus increasing regulatory compliance. More information can be found at www.cubex.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/cubex-llc-medbank-solutions-releases-significant-software-enhancement-providing-greater-security-for-controlled-substance-access-and-administration-300921905.html

SOURCE CUBEX LLC

Staff

Recent Posts

rYojbaba Co., Ltd. Announces Closing of $5 Million Initial Public Offering of Japanese Common Shares

FUKUOKA, Japan, Aug. 15, 2025 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) (“rYojbaba” or…

3 hours ago

Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH

Bagsværd, Denmark, 15 August 2025 – Novo Nordisk today announced that the US Food and Drug…

3 hours ago

BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering

Offering Structured to Accelerate Streamex’s Operational Build-Out, Strategically Allocated with No WarrantsLos Angeles, CA, Aug.…

3 hours ago

Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001

CRANBERRY TOWNSHIP, Pa., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Jabez Biosciences, Inc., a clinical-stage biopharmaceutical…

3 hours ago

4DMT Announces New Employment Inducement Grants

EMERYVILLE, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or…

3 hours ago